170 related articles for article (PubMed ID: 34710826)
21. [Antisense oligodeoxynucleotides of human telomerase reverse transcriptase inhibit endometrial carcinoma cell HEC-1A proliferation].
Chen XJ; Zheng W; Wang SQ
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):212-5. PubMed ID: 12839678
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and cellular activity of stereochemically-pure 2'-O-(2-methoxyethyl)-phosphorothioate oligonucleotides.
Li M; Lightfoot HL; Halloy F; Malinowska AL; Berk C; Behera A; Schümperli D; Hall J
Chem Commun (Camb); 2017 Jan; 53(3):541-544. PubMed ID: 27966701
[TBL] [Abstract][Full Text] [Related]
23. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
24. A Splice Intervention Therapy for Autosomal Recessive Juvenile Parkinson's Disease Arising from Parkin Mutations.
Li D; Aung-Htut MT; Ham KA; Fletcher S; Wilton SD
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019779
[TBL] [Abstract][Full Text] [Related]
25. In Vitro Validation of Phosphorodiamidate Morpholino Oligomers.
Aung-Htut MT; McIntosh CS; West KA; Fletcher S; Wilton SD
Molecules; 2019 Aug; 24(16):. PubMed ID: 31408997
[TBL] [Abstract][Full Text] [Related]
26. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
Echigoya Y; Lim KRQ; Trieu N; Bao B; Miskew Nichols B; Vila MC; Novak JS; Hara Y; Lee J; Touznik A; Mamchaoui K; Aoki Y; Takeda S; Nagaraju K; Mouly V; Maruyama R; Duddy W; Yokota T
Mol Ther; 2017 Nov; 25(11):2561-2572. PubMed ID: 28865998
[TBL] [Abstract][Full Text] [Related]
27. Antitumor mechanism of antisense cantide targeting human telomerase reverse transcriptase.
Du QY; Wang XB; Chen XJ; Zheng W; Wang SQ
World J Gastroenterol; 2003 Sep; 9(9):2030-5. PubMed ID: 12970900
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of telomerase activity by splice-switching oligonucleotides targeting the mRNA of the telomerase catalytic subunit affects proliferation of human CD4
Zhdanov DD; Plyasova AA; Gladilina YA; Pokrovsky VS; Grishin DV; Grachev VA; Orlova VS; Pokrovskaya MV; Alexandrova SS; Lobaeva TA; Sokolov NN
Biochem Biophys Res Commun; 2019 Feb; 509(3):790-796. PubMed ID: 30612734
[TBL] [Abstract][Full Text] [Related]
29. Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells.
Tao M; Miyano-Kurosaki N; Takai K; Takaku H
FEBS Lett; 1999 Jul; 454(3):312-6. PubMed ID: 10431829
[TBL] [Abstract][Full Text] [Related]
30. Exclusion of exon 2 is a common mRNA splice variant of primate telomerase reverse transcriptases.
Withers JB; Ashvetiya T; Beemon KL
PLoS One; 2012; 7(10):e48016. PubMed ID: 23110161
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of human telomerase by oligonucleotide chimeras, composed of an antisense moiety and a chemically modified homo-oligonucleotide.
Tarkanyi I; Horváth A; Szatmari I; Eizert H; Vámosi G; Damjanovich S; Ségal-Bendirdjian E; Aradi J
FEBS Lett; 2005 Feb; 579(6):1411-6. PubMed ID: 15733850
[TBL] [Abstract][Full Text] [Related]
32. Endosomal Escape of Antisense Oligonucleotides Internalized by Stabilin Receptors Is Regulated by Rab5C and EEA1 During Endosomal Maturation.
Miller CM; Wan WB; Seth PP; Harris EN
Nucleic Acid Ther; 2018 Apr; 28(2):86-96. PubMed ID: 29437530
[TBL] [Abstract][Full Text] [Related]
33. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.
Kraemer K; Fuessel S; Schmidt U; Kotzsch M; Schwenzer B; Wirth MP; Meye A
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3794-800. PubMed ID: 14506173
[TBL] [Abstract][Full Text] [Related]
34. Receptor-Mediated Uptake of Phosphorothioate Antisense Oligonucleotides in Different Cell Types of the Liver.
Miller CM; Tanowitz M; Donner AJ; Prakash TP; Swayze EE; Harris EN; Seth PP
Nucleic Acid Ther; 2018 Jun; 28(3):119-127. PubMed ID: 29425080
[TBL] [Abstract][Full Text] [Related]
35. Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides.
Aung-Htut MT; McIntosh CS; Ham KA; Pitout IL; Flynn LL; Greer K; Fletcher S; Wilton SD
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614438
[TBL] [Abstract][Full Text] [Related]
36. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.
Fu XH; Zhang JS; Zhang N; Zhang YD
World J Gastroenterol; 2005 Feb; 11(6):785-90. PubMed ID: 15682468
[TBL] [Abstract][Full Text] [Related]
37. Enhancements in the utilization of antigene oligonucleotides in the nucleus by booster oligonucleotides.
Wang L; Okamura H; Sasaki S; Taniguchi Y
Chem Commun (Camb); 2020 Aug; 56(67):9731-9734. PubMed ID: 32815931
[TBL] [Abstract][Full Text] [Related]
38. In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.
Nakamura A; Aoki Y; Tsoumpra M; Yokota T; Takeda S
Methods Mol Biol; 2018; 1828():151-163. PubMed ID: 30171540
[TBL] [Abstract][Full Text] [Related]
39. [Inhibitory effect of antisense human telomerase reverse transcriptase(hTERT) on telomerase activity of human pulmonary giant cell carcinoma cell line(PLA-801D)].
Ma XB; Han WD; Hao HJ; Li Q; Xu ZM; Lu XC; Zhao YL
Ai Zheng; 2003 Sep; 22(9):932-7. PubMed ID: 12969524
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer.
Qi Z; Mi R
Cancer Gene Ther; 2016 Jan; 23(1):36-42. PubMed ID: 26742579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
